The authors have indicated no significant interest with commercial supporters
Acquired Epidermodysplasia Verruciformis: A Comprehensive Review and a Proposal for Treatment
Version of Record online: 25 FEB 2013
© 2013 by the American Society for Dermatologic Surgery, Inc. Published by Wiley Periodicals, Inc.
Volume 39, Issue 7, pages 974–980, July 2013
How to Cite
Zampetti, A., Giurdanella, F., Manco, S., Linder, D., Gnarra, M., Guerriero, G. and Feliciani, C. (2013), Acquired Epidermodysplasia Verruciformis: A Comprehensive Review and a Proposal for Treatment. Dermatologic Surgery, 39: 974–980. doi: 10.1111/dsu.12135
- Issue online: 1 JUL 2013
- Version of Record online: 25 FEB 2013
Epidermodysplasia verruciformis (EV) is a rare genodermatosis characterized by immunologic abnormalities, disseminated human papilloma virus infection, and early development of skin cancers. Acquired forms have been rarely reported and usually occur with immunosuppression. The therapeutic management of the acquired forms is not standardized, and several therapies have been tried, with variable outcomes.
To provide updated clinical and experimental information on the treatment of acquired EV.
A Medline literature search was performed for relevant Medical Subject Heading terms, reviewing publications on strategies for management of acquired EV. We also report a case successfully treated using a combination of photodynamic therapy and oral retinoids.
Data from the literature show that a standardized approach to this condition is lacking; the combination treatment chosen in our case may be proposed because it led to an excellent clinical outcome and a long-lasting remission.